FDA
-
-
-
-
-
-
-
Morgan Stanley Downgrades Absci Corp. (ABSI) to Equalweight
-
-
-
-
-
-
-
Absci to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on December 11, 2025; Announces Accelerated Initiation of Phase 1/2a Trial
-
-
-
-
-
-
-
Absci Reports Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results
-
-
-
-
-
-
-
Absci Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
-
-
-
-
-
-
-
EQRx and Absci Announce Partnership to Discover and Develop Next-Generation Protein-Based Drugs
-
334,267 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


